Retrospective study of Effectiveness and safety of dolutegravir plus booster protease inhibitor regimen, after switching in HIV-positive patients
Latest Information Update: 27 Jan 2020
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 27 Jan 2020 New trial record